REQUEST A CONSULTATION

Ready to contact us for a consultation about your condition and our medical services? The staff of our Global Patient Services is ready to help. Please select the appropriate button to get started.
search
Covid-19

Positive Initial Results for Novel COVID-19 Drug Molnupiravir First Tested at Sheba

Molnupiravir
Studies indicate a quicker decline in the infectious virus among individuals with early COVID-19 treated with Molnupiravir

According to U.S. drugmaker Merck & Co Inc., initial results of studies on the experimental antiviral drug Molnupiravir it is developing with Ridgeback Bio suggest a reduction in the required duration for a negative COVID-19 indication from nasopharyngeal swab tests applied to study participants with early symptomatic COVID-19.

Sheba Medical Center was the first hospital in the world to collaborate with Merck & Co, Inc. and conduct a clinical trial of Molnupiravir on COVID-19, which was originally designed to combat the flu. Molnupiravir works by causing mutations in the enzyme responsible for replicating the virus.

Presently, Molnupiravir is in Phase II/III clinical trials, set to be completed by May.
“We are very pleased to share our initial Phase II infectivity data. At a time where there is an unmet need for antiviral treatments against COVID-19, we are encouraged by these preliminary data,” said Dr. Wendy Painter, Chief Medical Officer of Ridgeback Bio.

Related
Sheba and AMH
Sheba Medical Center Will Bring Innovative Healthcare to Bahrain Through a New Partnership Agreement
Aiming to benefit patients in the Persian Gulf through the sharing of medical expertise, Sheba has concluded a partnership with Bahrain’s American Mission Hospital (AMH),…
Read More
Aid Ukrainian Children
Sheba Partners with Oranim Academic College to Aid Ukrainian Children
As the war between Russia and Ukraine rages on, children are not exempt from traumatic experiences, which often include being forced to leave their homes,…
Read More
Sheba and TJU
A Collaboration Between Sheba and TJU: Advancing Neuroscience
Despite the vast amount of knowledge gathered owing to the sophisticated imaging devices that have been developed in recent years, considerable research budgets allocated to…
Read More